Quick Comparison

Matrixyl (Palmitoyl Pentapeptide-4)Niacinamide
Typical ConcentrationTypically used at 2-8% in formulations. Applied morning and/or night. Compatible with virtually all other active ingredients. Often found combined with Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) for enhanced effects.Concentrations: 2-10%. 5% is the most studied concentration and provides the best balance of efficacy and tolerability. Higher concentrations (10%) are available but may cause irritation in sensitive skin without proportional benefit. Apply morning and/or night.
ApplicationTopical (serum, cream). Water-soluble base. Apply to clean skin. Compatible with acids, retinoids, and vitamin C.Topical (serum, moisturizer, toner). Water-soluble. Stable in formulation. Compatible with most actives.
Research Papers2 papers10 papers
Categories

Mechanism of Action

Matrixyl (Palmitoyl Pentapeptide-4)

Matrixyl (palmitoyl pentapeptide-4, Pal-KTTKS) is a matrikine—a bioactive collagen fragment mimicking Lys-Thr-Thr-Lys-Ser from the alpha-1 chain of collagen I. This sequence binds integrin receptors on dermal fibroblasts, triggering TGF-beta/Smad and MAPK/ERK signaling that upregulates ECM synthesis genes. Fibroblasts increase production of collagen I, III, IV, fibronectin, elastin, and glycosaminoglycans including hyaluronic acid—recreating the wound-healing signal without tissue damage. The C16 palmitoyl chain enhances lipophilicity and stratum corneum penetration via intercellular lipid partitioning. Unlike retinoids, Matrixyl does not accelerate epidermal turnover, explaining its lack of irritation. Clinical studies show wrinkle reduction comparable to retinol.

Niacinamide

Niacinamide is converted to NAD+ via the Preiss-Handler pathway—essential for cellular respiration, DNA repair (PARP), and sirtuin regulation. In keratinocytes, it upregulates serine palmitoyltransferase and fatty acid elongases, increasing ceramide synthesis and strengthening the barrier. It inhibits melanosome transfer by downregulating protease-activated receptor-2 (PAR-2) on keratinocytes—brightening without tyrosinase inhibition. In sebocytes, it normalizes lipid synthesis and reduces sebum (possibly via AMPK). Niacinamide inhibits NF-kB translocation, suppressing IL-1beta, TNF-alpha, and IL-8. It inhibits phosphodiesterase, increasing cAMP and modulating keratinocyte differentiation. These multi-pathway effects explain broad efficacy across barrier repair, brightening, acne, and anti-aging.

Risks & Safety

Matrixyl (Palmitoyl Pentapeptide-4)

Common

Essentially none — peptides are extremely well-tolerated.

Serious

None documented. Safe in pregnancy.

Rare

Minimal risk of allergic reaction.

Niacinamide

Common

Very well-tolerated at 2-5%. Flushing/redness at concentrations above 5% in some individuals.

Serious

None documented.

Rare

Contact dermatitis (uncommon). Old advice to avoid combining with vitamin C is largely debunked at product pH levels.

Full Profiles